Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

Similiar legislation died last year after getting House approval.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...

Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth ...

Pratt and Montag are also among over 20 homeowners from the Pacific Palisades who are suing the city of Los Angeles, along ...

Biomarin Pharmaceutical Inc (BMRN) stock saw a modest uptick, ending the day at $61.8 which represents a slight increase of $0.07 or 0.11% from the prior close of $61.73. The stock opened at $62.1 and ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREPARE ...

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...